|
Thyroid
Levothyroxine a New Drug? Since When? How Could That Be?
To cite this article:
James V. Hennessey.
Thyroid.
March 2003,
13(3): 279-282.
doi:10.1089/105072503321582088.
Published in Volume: 13 Issue 3: July 9, 2004
James V. Hennessey Division of Endocrinology, Brown Medical School, Rhode Island Hospital, Providence, Rhode Island.  This paper was cited by:TSH-Based Protocol, Tablet Instability, and Absorption Effects on L-T4 Bioequivalence Marisa Eisenberg, Joseph J. Distefano III Thyroid. Feb 2009, Vol. 19, No. 2: 103-110 Abstract | Full Text PDF | Reprints & PermissionsThe FDA Revises Requirements for Levothyroxine Products Kenneth Burman, James Hennessey, Michael McDermott, Leonard Wartofsky, Charles Emerson Thyroid. May 2008, Vol. 18, No. 5: 487-490 First Page | Full Text PDF | Reprints & PermissionsDevelopment and validation of an inductively coupled plasma mass spectrometry method for quantification of levothyroxine in dissolution studies Dimple Pabla, Fatemeh Akhlaghi, Aftab Ahmed, Hossein Zia Rapid Communications in Mass Spectrometry. Apr 2008, Vol. 22, No. 7: 993-996 CrossRef L-T4 Bioequivalence and Hormone Replacement Studies via Feedback Control Simulations Marisa Eisenberg, Mary Samuels, Joseph J. DiStefano III Thyroid. Dec 2006, Vol. 16, No. 12: 1279-1292 Abstract | Full Text PDF | Reprints & PermissionsL-T
4
Bioequivalence and Hormone Replacement Studies via Feedback Control Simulations Marisa Eisenberg, Mary Samuels, Joseph J. DiStefano Thyroid. Dec 2006, Vol. 16, No. 12: 1279-1292 CrossRef Levothyroxine dosage and the limitations of current bioequivalence standards James V Hennessey Nature Clinical Practice Endocrinology & Metabolism. Sep 2006, Vol. 2, No. 9: 474-475 CrossRef Thyroid Medications During Pregnancy Thien-Giang Bach-Huynh, Jacqueline Jonklaas Therapeutic Drug Monitoring. Jun 2006, Vol. 28, No. 3: 431-441 CrossRef New questions regarding bioequivalence of levothyroxine preparations: A Clinician's response William L. Green The AAPS Journal. Mar 2005, Vol. 7, No. 1: E54-E58 CrossRef Testing the Bioavailability of Oral L-Thyroxine by Studying Its Absorption: Smoke or Mirrors? Jim Stockigt Thyroid. Mar 2004, Vol. 14, No. 3: 167-168 First Page | Full Text PDF | Reprints & PermissionsThyrotropin Receptor Cleavage Domain and Tissue Inhibitor of Metalloproteinase-2 Ricardo Nunez Miguel, Jane Sanders, Jennifer Jeffreys, Hilde Depraetere, Tom Blundell, Jadwiga Furmaniak, Bernard Rees Smith Thyroid. Jul 2003, Vol. 13, No. 7: 665-666 First Page | Full Text PDF | Reprints & PermissionsBioavailability of Levothyroxine Preparations Klaus Werner Wenzel Thyroid. Jul 2003, Vol. 13, No. 7: 665-665 First Page | Full Text PDF | Reprints & Permissions
 | Bioavailability of Levothyroxine Preparations Klaus Werner WenzelThyroid.
July 2003: 665-665. First Page | Full Text PDF | Reprints & Permissions | |
 | TSH-Based Protocol, Tablet Instability, and Absorption Effects on L-T4 Bioequivalence Marisa Eisenberg, Joseph J. Distefano IIIThyroid.
February 2009: 103-110. Abstract | Full Text PDF | Reprints & Permissions | |
 | The FDA Revises Requirements for Levothyroxine Products Kenneth Burman, James Hennessey, Michael McDermott, Leonard Wartofsky, Charles EmersonThyroid.
May 2008: 487-490. First Page | Full Text PDF | Reprints & Permissions | |
 | Evaluation of the Therapeutic Efficacy of Different Levothyroxine Preparations in the Treatment of Human Thyroid Disease Irwin Klein, Sara DanziThyroid.
December 2003: 1127-1132. Abstract | Full Text PDF | Reprints & Permissions | |
 | My Thyroid Tablets, Your Thyroid Tablets: Are They All the Same? Terry F. DaviesThyroid.
July 2004: 485-485. First Page | Full Text PDF | Reprints & Permissions | |
 | Testing the Bioavailability of Oral L-Thyroxine by Studying Its Absorption: Smoke or Mirrors? Jim StockigtThyroid.
March 2004: 167-168. First Page | Full Text PDF | Reprints & Permissions | |
|
|